- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- November 2025
- 182 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- June 2025
- 190 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- March 2025
- 185 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- March 2025
- 182 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- February 2025
- 180 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- February 2025
- 180 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- January 2025
- 180 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- January 2025
- 180 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- August 2025
- 180 Pages
Global
From €3116EUR$3,545USD£2,716GBP
€3463EUR$3,939USD£3,018GBP
- Report
- January 2025
- 124 Pages
Global
From €2241EUR$2,549USD£1,953GBP
€2636EUR$2,999USD£2,298GBP
- Report
- November 2025
- 200 Pages
Global
From €5591EUR$6,360USD£4,873GBP
€6989EUR$7,950USD£6,091GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1407EUR$1,600USD£1,226GBP
€1758EUR$2,000USD£1,532GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more